SPOTLIGHT -
RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression
Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
The Prospect of Experiential Training
A look into the experiential learning process involving ketamine.
No, Psychiatric Diagnoses Do Not Reflect “Circular Logic”
Not knowing the pathophysiology of a condition does not mean we have no causal explanation of the patient’s suffering and incapacity.
Clinical Trials of Prescription Digital Therapeutics for Schizophrenia
An update on recent advances and learnings from ongoing studies.
Treatment of Parental Alienation: Guidelines for Mental Health and Legal Practitioners
Mental health clinicians and legal practitioners can learn more about parental alienation and its treatment here.
Facilitating Conflict Resolution
Check out these recommendations for facilitating conflict resolution.
The Complexity of Climate Change as a Determinant of Mental Health
How does climate change affect mental health in individuals and communities?
A Psychiatrist’s Journey in Social Media Advocacy and Clinical Research
Judith Joseph, MD, MBA, shares her journey of balancing clinical work with social media mental health advocacy.
Lifestyle Psychiatry: Evidence-Based Lifestyle Interventions for Mental and Physical Health
What is lifestyle psychiatry, and how can it benefit our patients?
The Effects of Multidose Ketamine Treatment on Cognitive Performance Over Time in Patients With TRD
Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.
Travel as Therapy
Travel: how can it heal you?
A Look at the Comorbidity of Eating Disorders and Addiction
An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.
Approved sNDA: Wakix for Treatment of Excessive Daytime Sleepiness in Youth With Narcolepsy
The FDA has approved its supplemental New Drug Application for Wakix tablets for the treatment of excessive daytime sleepiness in pediatric patients aged 6 years and older with narcolepsy.
Disabilities: The Next Chapter in DEI
Additionally, 27% of US adults have reported they have a disability across a spectrum of areas.
Some Social Psychoexemplaries
Do we need a potential classification of social psychoexemplaries?
The Week in Review: June 17-21
Here are highlights from the week in Psychiatric Times.
First Nontobacco Flavored E-Cigarette Products Authorized by the FDA
The FDA has authorized the marketing of 4 menthol-flavored e-cigarette products in the United States through the premarket tobacco product application pathway.
Countertransference in Physician-Assisted Suicide: A Hypothesis
What role does countertransference play in physician-assisted suicide? Learn more here.
Investigating the Link Between Semaglutide and Suicidal Ideation
Recent research found approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.
Questions About Angels
"Of all the questions you might want to ask about angels, the only one you ever hear is how many can dance on the head of a pin..."
Forgiveness and Beyond
When is forgiveness not enough?
“The Experimental Child”: Children and the COVID-19 Syndemic
Children are subject to the world’s largest biosocial experiment.
Apex Labs Files IND Application for APEX-52 Study of Take-Home Microdose Psilocybin
The outcomes of this study are expected to inform the development of the upcoming PATHFINDER-52 phase 2b clinical trial.
Questions and Answers About Clozapine: A Dialogue About the Use of Plasma Levels
In this CME article, read more about best practices for utilizing clozapine plasma levels and the clozapine/norclozapine ratio to monitor clozapine therapy.
Phase 2 Study Initiated: ALTO-101 for Cognitive Impairment With Schizophrenia
ALTO-101 has previously been shown to positively impact cognition in schizophrenia.
A Brief Cannabis Cessation Protocol to Increase Patient Motivation
Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?
Say Hey, Kids: It’s Juneteenth Day!
Yesterday, we celebrated Juneteenth.
Summertime and the Living Isn't Easy
Are we ready for summer?
Technology at the Forefront: Shaping the Future of Psychiatry Certification
How can artificial intelligence enhance psychiatry certification, and how do we implement it?
How to Safely and Effectively Taper Benzodiazepines
Review tapering challenges and strategies for benzodiazepines in this Special Report article.